Eagle Bancorp to Participate in the 2024 Hovde Group Financial Services Conference
BETHESDA, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company of […]
Northfield Capital Invests in Hemlo Explorers
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Northfield Capital Corporation (TSX-V: NFD.A) (the “Company”) is pleased to announce that it […]
TSX News -
Eloro Resources Closes Non-Brokered Private Placement Offering of 4,200,000 units for Gross Proceeds of $3,780,000
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE […]
Hemlo Explorers Announces Closing of Non-Brokered Private Placement
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to announce that it […]
Newbury Street II Acquisition Corp. Announces the Pricing of $150,000,000 Initial Public Offering
New York, NY, Oct. 31, 2024 (GLOBE NEWSWIRE) — Newbury Street II Acquisition Corp. (the “Company”) today announced the pricing […]
Lavoro Reports Fiscal Fourth Quarter 2024 Earnings Results¹
FY2024 revenue of US$1.89 billion increased 5% year-over-year (flat in BRL terms), driven by market share gains and sales volume […]
Brookfield Announces Steps to Enhance Corporate Structure and Broaden Shareholder Ownership of Brookfield Asset Management
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) — Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) and Brookfield Corporation (NYSE: […]
TSX News -
Black Diamond Reports Third Quarter 2024 Results and Increases Dividend by 17%
CALGARY, Alberta, Oct. 31, 2024 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond”, the “Company” or “we”), (TSX:BDI), a […]
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
THE WOODLANDS, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the […]
Bleichroeder Acquisition Corp. I Announces the Pricing of $250,000,000 Initial Public Offering
New York, NY, Oct. 31, 2024 (GLOBE NEWSWIRE) — Bleichroeder Acquisition Corp. I (the “Company”) announced today the pricing of […]
